Recent innovations in the USA National Cancer Institute-sponsored investigator initiated Phase I and II anticancer drug development: Figure 1.
2015 ◽
Vol 45
(11)
◽
pp. 1001-1006
◽
Hideaki Bando
◽
Naoko Takebe
2003 ◽
Vol 52
(0)
◽
pp. 29-33
◽
2012 ◽
Vol 23
(11)
◽
pp. 2960-2963
◽
A. Naing
◽
H. Veasey-Rodrigues
◽
D.S. Hong
◽
S. Fu
◽
G.S. Falchook
◽
...
2010 ◽
Vol 15
(3-4)
◽
pp. 88-97
◽
Craig P. Carden
◽
Debashis Sarker
◽
Sophie Postel-Vinay
◽
Timothy A. Yap
◽
Gerthardt Attard
◽
...
Abhijit Pal
◽
Rajiv Shinde
◽
Manuel Selvi Miralles
◽
Paul Workman
◽
Johann de Bono
1992 ◽
Vol 5
(5)
◽
pp. 270-272
◽
Paul Workman
◽
Ross J. Maxwell
◽
John R. Griffiths
2008 ◽
Vol 44
(4)
◽
pp. 494-500
◽
Giuseppe Curigliano
◽
Gianluca Spitaleri
◽
Howard J. Fingert
◽
Filippo de Braud
◽
Cristiana Sessa
◽
...
1981 ◽
Vol 17
(9)
◽
pp. 1067
2014 ◽
Vol 13
(3)
◽
pp. 179-196
◽
Matthias Dobbelstein
◽
Ute Moll